The forces shaping markets and the economy are often hiding behind a blur of numbers.

So that's why we created The Big Take from Bloomberg Podcasts, to give you the context you need to make sense of it all.

Every day in just 15 minutes, we dive into one global business story that matters.

You'll hear from Bloomberg journalists like Matt Levine.

A lot of this meme stock stuff is, I think, embarrassing to the SEC.

Follow the Big Take podcast on the IHeart Radio app, Apple Podcasts, or wherever you listen. Learning that you have cancer can be terrifying.

And every two seconds, somewhere in the world, another person gets the diagnosis.

That's four people just since I started talking.

But there are places where the fear of dying from cancer is amplified by an added, treacherous

risk, that the cancer treatment will bring on a deadly infection from a killer superbug,

that even the most potent antibiotics available are powerless to tame.

It's called extreme drug resistance, and it can create a devastating dilemma for some patients.

The treatment for their tumors may kill them faster than the tumors themselves.

Welcome to Prognosis, a podcast about health and science, medical technology, and the changes that are underway across the world.

I'm your host, Michelle Faye Cortez.

This season, we're examining one of the dangers that keeps public health officials awake at night.

It's been described as a silent tsunami of catastrophic proportions.

One of the gravest threats to human health. I'm talking about antimicrobial resistance.

More commonly known as the irreversible rise of superbugs. The waning potency of critical antibiotics

is happening faster than even the most dire forecasts. Tragically, cancer patients are at the front line of this global emergency.

The conundrum is playing out sporadically in hospitals in many countries,

portending a global problem.

...